En Es
Categories

Industry News

JNJ Acquires Remaining Stake in Verb Surgical

By HospiMedica International staff writers
27 Jan 2020

IllustrationJohnson & Johnson (New Brunswick, N.J., USA) has acquired the remaining stake in Verb Surgical Inc. (Santa Clara, CA, USA), following a successful strategic collaboration with Verily, an Alphabet company. Verb Surgical's robotics and data science capabilities, combined with Johnson & Johnson's health care leadership and global reach, aim to make medical interventions smarter, less invasive and more personalized.

Johnson & Johnson continues to strengthen its digital surgery portfolio by combining ground-breaking robotics, enhanced visualization, advanced instrumentation, machine learning, data analytics and powerful end-to-end connectivity. Verb Surgical's leading-edge robotics and data science expertise, as well as its digital technology and engineering expertise, make Johnson & Johnson well-positioned to bring its insights and experience in science, medical technology and digital solutions to medical interventions, including open surgery, laparoscopic, percutaneous and endoluminal procedures.

"We have reached this important milestone thanks to the progress the Verb Surgical team has made with their digital surgery platform and the strong collaboration with Verily, Ethiconii, and the clinicians around the world who shared their passion, deep insights and clinical expertise," said Ashley McEvoy, worldwide chairman, Medical Devices, Johnson & Johnson. "We are building a truly differentiated digital surgery ecosystem to change the standard of care for generations to come, and our collaboration with Verily has enabled us to advance our vision to help improve outcomes for patients around the world."

"With Verb Surgical, we set out with an ambitious mission to successfully harmonize the talent and expertise of two pioneers to design a platform with the potential to transform surgery," said Andrew Conrad, CEO of Verily. "This evolution in the collaboration recognizes the significant achievement toward that mission and I'm excited for the future of this technology in Johnson & Johnson's hands."

Related Links:
Johnson & Johnson
Verb Surgical Inc.




E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

23 Mar 2020
Artificial Intelligence-Based Methods to Cut MRI Read Times Receives USD 250K Grant
 Research to detect and predict blocked arteries and cardiovascular risk using knee MRI images conducted by Chun Yuan, Ph.D., Professor of Radiology and Bioengineering and Vice Chair for Global Affairs at the University of Washington (Seattle, WA, USA) has been recognized and awarded a grant by the American Heart Association’s (AHA) Institute for Precision Cardiovascular Medicine (Dallas, TX, USA).
Read More
23 Mar 2020
Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions
 The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are finding increased acceptance in the emerging Asia region, according to a study by Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider. The study is based on recent findings by IEEE (an Association for Electronic Engineering) that millennial parents are increasingly opting for robotic surgeries for their children in Asia Pacific region. The study also reveals that low availability of robotic surgeries remains a concern.
Read More
19 Mar 2020
Advantech Launches Medical-Grade AVAS-400 Series 4K UHD Video Recorder
 Advantech Co., Ltd. (Taipei, Taiwan), a provider of medical computing platforms and solutions, has launched its AVAS-400 Series medical-grade 4K ultra high-definition (UHD) video recorder aimed at ensuring operating precision. Advantech’s AVAS-400 Series, which includes two models, the AVAS-401 and the AVAS-402, are ideal for surgery centers, operating rooms, and training facilities that use 4K UHD cameras and display monitors for surgical operations and post-surgery reviews and research.
Read More
19 Mar 2020
Artificial Intelligence Helps Cancer Patients Start Radiation Therapy Sooner
 A new study by researchers from UT Southwestern’s Medical Artificial Intelligence and Automation (MAIA) Lab (Dallas, TX, USA) has demonstrated that artificial intelligence (AI) can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.
Read More
18 Mar 2020
Global Radiation Therapy Market to Reach USD 8.6 Billion by 2026 on Back of Product Approvals
 The global radiation therapy market is projected to record a steady growth rate of 5.2% from 2018 to 2026 to reach USD 8.6 billion by 2026, driven by a surge in product approvals, increased expenditure on healthcare, high incidence of cancer, growing preference for non-invasive treatment procedures, technological advancements, and notable research and development activities.
Read More
18 Mar 2020
Global Multiparameter Patient Monitoring Devices Market to Reach USD 6 Billion by 2025
 The global multiparameter patient monitoring devices market is expected to grow at a CAGR of over 4%, or record an incremental growth of around USD 1.32 billion, during the forecast period 2019?2025 to reach USD 6 billion in 2025. These are the latest findings of Arizton (Chicago, IL, USA), a provider of market research solutions.
Read More
17 Mar 2020
AI-based Ultrasound Echo Imaging Software Receives FDA Marketing Authorization
 The US Food and Drug Administration (FDA) has authorized the marketing of a software that uses artificial intelligence (AI) to assist medical professionals in the acquisition of cardiac ultrasound images. The software, Caption Guidance from Caption Health (Brisbane, CA, USA), a medical AI company, uses AI to empower medical professionals without specialized training to perform cardiac ultrasound.
Read More
17 Mar 2020
Global Defibrillators Market Projected to Reach USD 11.7 Billion by 2025
 The global defibrillators market is projected to grow at a CAGR of 3.4% from USD 9.6 billion in 2019 to USD 11.7 billion by 2025, driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. Additionally, the emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for the players in the defibrillators market. However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and lack of awareness about sudden cardiac arrest in the developing countries are expected to hinder the growth of the market during the forecast period.
Read More
16 Mar 2020
Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
 The global blood glucose monitoring devices (BGMDs) market was valued at nearly USD 8 billion in 2018 and is projected to grow at a fast-paced CAGR of approximately 11% to reach USD 13 billion by 2023, driven by the phenomenal sales growth of new revolutionary continuous glucose monitoring systems (CGMs). However, the growth of CGMs will be offset by a steady decline in the blood glucose meters (BGMs) segment due to continued extreme price competition/downward pricing pressure, lowered test-strip reimbursement, and market saturation of lower-cost meters, among other factors.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions